U.S. In Vitro Diagnostics Market worth 25.99 Billion USD by 2020 U.S. In Vitro Diagnostics Market worth 25.99 Billi | Page 14

6

U. S. IN VITRO DIAGNOSTICS MARKET, BY PRODUCT & SERVICE........................................... 43

• 6.1

INTRODUCTION............................................................................................................................................................... 44

• 6.2

REAGENTS....................................................................................................................................................................... 46

• 6.3

INSTRUMENTS................................................................................................................................................................. 47

• 6.3.1

FULLY AUTOMATED INSTRUMENTS............................................................................................................. 48

• 6.3.2

SEMI-AUTOMATED INSTRUMENTS.............................................................................................................. 49

• 6.3.3

OTHERS......................................................................................................................................................... 49

• 6.4

DATA MANAGEMENT SOFTWARE.................................................................................................................................... 50

• 6.5

SERVICES......................................................................................................................................................................... 51

7

U. S. IN VITRO DIAGNOSTICS MARKET, BY TECHNOLOGY....................................................... 52

• 7.1

INTRODUCTION............................................................................................................................................................... 53

• 7.2

CLINICAL CHEMISTRY.................................................................................................................................................... 54

• 7.3

IMMUNOCHEMISTRY / IMMUNOASSAYS......................................................................................................................... 55

• 7.4

MICROBIOLOGY............................................................................................................................................................... 56

• 7.5

MOLECULAR DIAGNOSTICS( MDX)................................................................................................................................ 57

• 7.6

HEMATOLOGY.................................................................................................................................................................. 58

• 7.7

COAGULATION / HEMOSTASIS.......................................................................................................................................... 59

• 7.8

OTHER IVD TECHNOLOGIES............................................................................................................................................ 60

8

U. S. IN VITRO DIAGNOSTICS MARKET, BY APPLICATION........................................................ 61

• 8.1

INTRODUCTION............................................................................................................................................................... 62

• 8.2

INFECTIOUS DISEASES................................................................................................................................................... 63

• 8.3

DIABETES......................................................................................................................................................................... 65

• 8.4

ONCOLOGY / CANCER....................................................................................................................................................... 66

• 8.5

CARDIOVASCULAR DISORDERS..................................................................................................................................... 67

• 8.6

ENDOCRINE DISORDERS................................................................................................................................................. 68

• 8.7

AUTOIMMUNE DISEASES................................................................................................................................................ 70

• 8.8

BONE & MINERAL-RELATED DISEASES.......................................................................................................................... 71

• 8.9

PULMONARY DISEASES.................................................................................................................................................. 72

• 8.10

OTHER APPLICATIONS.................................................................................................................................................... 73

•